Sorriso Pharmaceuticals Inc.
- Address
- 9295 South 1300 East Suite 3
Sponsor Overview
Specializations
Gastroenterology and Inflammatory Bowel Disease
Sorriso Pharmaceuticals Inc. is engaged in clinical research centred on ulcerative colitis, with interest in the broader management of chronic gastrointestinal inflammation and related digestive tract disorders.
- Ulcerative colitis
- Inflammatory bowel disease
- Gastrointestinal inflammation
The sponsor’s trial activity reflects a focus on therapeutic areas relevant to colonic mucosal disease and symptom control in patients with persistent intestinal inflammation.
Immunology and Immune-Mediated Disorders
Its research interests include conditions driven by abnormal immune system activity, particularly disorders characterised by ongoing inflammatory responses in the bowel.
- Immune-mediated inflammation
- Autoimmune-related intestinal disease
- Mucosal immune dysfunction
This area aligns with investigation of therapies intended to address the underlying inflammatory biology of ulcerative colitis.
Clinical Safety and Patient Tolerability
The sponsor also shows interest in safety assessment and tolerability across both healthy participants and individuals affected by ulcerative colitis, supporting evaluation of treatment suitability in different populations.
- Safety evaluation
- Tolerability assessment
- Healthy volunteer research
These themes are relevant to early clinical development in inflammatory disease settings.
Digestive Tract Therapeutics
Research activity supported by the company is focused on therapies for the lower gastrointestinal tract, with emphasis on disease areas where inflammation affects bowel function and quality of life.
- Colonic disease
- Intestinal inflammation
- Therapeutics for bowel disorders
This includes interest in treatment approaches directed at chronic colitis and related digestive-system conditions.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Safety Evaluation of SOR102 in Healthy Subjects and Ulcerative Colitis Patients: A Phase I Clinical Trial |  Bulgaria Poland | Not Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 7 sites across their trial portfolio.
Therapeutic Focus
- 1.Digestive System Diseases1 trial280 other sponsors
Partnered Research Centres
7 centres- Address
- Ul. Ulica Jozefa Sierakowskiego 4/u3, 03-712 Warsaw
- Address
- Ul. Boleslawa Chrobrego 6/8, 81-756 Sopot
- Address
- Bulevard Bilgariya 104, 1404 Sofia
- Address
- Ul. Zamiejska 17, 03-580 Warsaw
- Address
- Ul. Lubinowa 12/8, 52-210 Wroclaw
- Address
- Ul. Uniczowska 6, 40-748 Katowice
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Sorriso Pharmaceuticals Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.